Isomorphic Labs in talks to raise $5bn at a $50bn valuation, Bloomberg reports

Isomorphic Labs, the drug discovery company spun out of Google DeepMind, is in talks to raise about $5bn, Bloomberg reported on Wednesday. The round would put the Isomorphic…

Isomorphic Labs, the drug discovery company spun out of Google DeepMind, is in talks to raise about $5bn, Bloomberg reported on Wednesday. The round would put the Isomorphic Labs valuation at about $50bn, according to people familiar with the matter. The financing has not closed and the details could change, the people told Rebecca Torrence […] This story continues at The Next Web